Plus, DaVita and Medtronic launch kidney care company

This Week

Apr 8, 2023

CMS to raise Medicare Advantage pay rates by 3.3% in 2024; phase in risk adjustment changes


DaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care


Providers, payers press CMS to get rid of Medicare Advantage risk adjustment changes entirely - Robert King

 

Featured

CMS to raise Medicare Advantage pay rates by 3.3% in 2024; phase in risk adjustment changes

CMS finalized a 3.3% pay bump to Medicare Advantage plans for 2024 after proposing a 1% raise that some plans saw as a cut, and will phase in changes to risk adjustment over three years.
 

Top Stories

DaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care

Mozarc Medical, a new kidney tech company jointly owned by DaVita and medical device company Medtronic, officially launched on Saturday. Announced nearly a year ago, the new venture aims to bring more innovation to kidney care, with a specific focus on at-home treatments.

Providers, payers press CMS to get rid of Medicare Advantage risk adjustment changes entirely

Provider and payer groups are aiming to keep a close eye on how CMS will phase-in key changes to Medicare Advantage's risk adjustment detailed in a final rule.

ACA benchmark premiums rise 3.4% for 2023 as rate of new insurers slowed: study

Average premiums for Affordable Care Act plans increased by more than 3% for 2023 as the rate of new insurer entrants slowed, a report found.

From 'transformative' to 'tremendous fear': Takes on ChatGPT in healthcare at ViVE 2023

NASHVILLE, Tennessee—From “transformative” to inducing heartburn in security experts, there was no shortage of opinions about the use of ChatGPT in healthcare at ViVE 2023 in Nashville, Tennessee last month.

Cano Health stock surges Monday as former directors make a push to replace CEO, sell assets

Cano Health shares jumped more than 40% Monday after three former directors signaled they intend to form a group to "pursue changes" at the company, including possible moves to oust the CEO and the sale of non-core assets. The company's stock tumbled 27% Friday to below $1 per share after three board directors including early investor Barry Sternlicht resigned in protest of the primary care company's management.

CMS finalizes changes to Medicare Advantage star ratings, prior authorization reforms

CMS finalized a rule that includes new prior authorization requirements for Medicare Advantage plans and a health equity index into star ratings.

Study: Cuts to Medicare Advantage payments may have modest impact on seniors' benefits

A new study in Health Affairs finds a decline in Medicare Advantage payments would only lead to a modest impact on benefits for seniors.

Medicaid redeterminations can officially resume. Here's how Elevance Health is responding

States won't be on their own to navigate this process, however, as commercial insurers in the Medicaid space are gearing up to assist.

HHS quietly trims inaugural list of price capped Medicare drugs from 27 to 20

The Biden administration initially hailed the collection of new drug rebates as a victory against Big Pharma. The last-minute change now has drug makers alleging a hasty rollout.
 
Fierce podcasts

Don't miss an episode

'Podnosis': Tackling adolescent mental health, and how inflation and labor shortages will play out in Medicare Advantage

This week on "Podnosis," we discuss the rising tide of mental health concerns among young people. We also talk about how inflation and labor shortages will play out in Medicare Advantage.
 

Resources

Research

Case Study: Improving outcomes and efficiency with one data view

Learn why integrating your quality and risk data is a game-changer.
 

Upcoming Fierce Events

1-3
May
May 1-3, 2023 | Jersey City, NJ
22
Jun
Free Virtual Event
18-19
Jul
July 18-19, 2023 | Jersey City, NJ
1
Aug
Date TBD | Boston, MA
11-14
Sep
Philadelphia, PA

View all events